- 5 Results
Lowest price: € 159.65, highest price: € 254.41, average price: € 195.59
1
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Order
at Springer.com
€ 166.59
OrderSponsored link
Ali M. Emran:

New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - new book

ISBN: 9781489906267

Marking the 200th National Meeting of the American Chemical Society, The Division of Nuclear Chemistry and Technology hosted a group of about 90 scientists from 15 different countries to … More...

  - new in stock. Shipping costs:zzgl. Versandkosten., plus shipping costs
2
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Order
at Springer.com
€ 160.49
Shipment: € 0.001
OrderSponsored link
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - new book

ISBN: 9781489906267

Marking the 200th National Meeting of the American Chemical Society, The Division of Nuclear Chemistry and Technology hosted a group of about 90 scientists from 15 different countries to … More...

Nr. 978-1-4899-0626-7. Shipping costs:Worldwide free shipping, , DE. (EUR 0.00)
3
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Order
at Springer.com
€ 236.81
OrderSponsored link
Ali M. Emran:
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - new book

ISBN: 9781489906267

Biomedicine; Pharmacology/Toxicology; Nuclear Medicine; Ultrasound; Organic Chemistry cancer, chemistry, computer, imaging, nuclear medicine, positron emission tomography (PET), radiology… More...

  - Shipping costs:zzgl. Versandkosten., plus shipping costs
4
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Order
at lehmanns.de
€ 159.65
Shipment: € 0.001
OrderSponsored link
Ali M. Emran:
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - new book

2013, ISBN: 9781489906267

eBooks, eBook Download (PDF), [PU: Springer US], Springer US, 2013

Shipping costs:Download sofort lieferbar. (EUR 0.00)
5
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - Ali M. Emran
Order
at lehmanns.de
€ 254.41
Shipment: € 0.001
OrderSponsored link
Ali M. Emran:
New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control - new book

2013, ISBN: 9781489906267

eBook Download (PDF), eBooks, [PU: Springer]

  - Shipping costs:Download sofort lieferbar, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)

1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by find-more-books.com / find-more-books.com do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book

Details of the book - New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control


EAN (ISBN-13): 9781489906267
Publishing year: 2013
Publisher: Springer US

Book in our database since 2016-05-15T05:53:02-04:00 (New York)
Detail page last modified on 2024-01-31T14:39:43-05:00 (New York)
ISBN/EAN: 9781489906267

ISBN - alternate spelling:
978-1-4899-0626-7
Alternate spelling and related search-keywords:
Book title: quality assurance


Information from Publisher

Author: Ali M. Emran
Title: New Trends in Radiopharmaceutical Synthesis, Quality Assurance, and Regulatory Control
Publisher: Springer; Springer US
520 Pages
Publishing year: 2013-11-09
New York; NY; US
Language: English
213,99 € (DE)
220,00 € (AT)
236,00 CHF (CH)
Available
XI, 520 p.

EA; E107; eBook; Nonbooks, PBS / Medizin/Pharmazie; Pharmakologie; Verstehen; cancer; chemistry; computer; imaging; nuclear medicine; positron emission tomography (PET); radiology; research; Ultrasonography; C; Pharmacology; Nuclear Medicine; Ultrasonics; Organic Chemistry; Biomedical and Life Sciences; Nuklearmedizin; Akustik und Tontechnik; Organische Chemie; BB

1.1 Introductory Remarks.- 1.2 Overview.- 1.3 A Muscarinic Receptor Ligand: Review of the Chemistry and Applications.- 2.1 Aspects on the Synthesis and Design of 11C-Tracers for PET.- 2.2 Special Problems Associated with the Synthesis of High Specific Activity Carbon-11 Labeled Radiotracers.- 2.3 PET Radiopharmaceuticals via Reductive Carboxylation.- 2.4 [13N] Labeled Tracers, Synthesis and Applications.- 2.5 Cu1+ Assisted Nucleophilic Exchange Radiohalogenation: Application and Mechanistic Approach.- 2.6 Potential Breast Tumor Imaging Agents: Fluorotamoxifen and Derivatives.- 2.7 Fluorinated Azabicycloesters as Muscarinic Receptor Ligands for Application with PET.- 2.8 Flourine-18 Ligands for the In Vivo Study of ?-Adrenergic Receptors in the Heart and Lung.- 2.9 Design and Radiofluorination of Benzamide Dopamine D2 Receptor Ligands.- 3.1 A Synthetic Porphyrin with High Affinity for Lung Cancer Cells and Inflamed Lymphatic Tissue.- 3.2 Galium and Copper Radiopharmaceutical Chemistry.- 3.3 Radiometallating Antibodies and Autoantigenic Peptides.- 3.4 Biomedical Use of Arsenic Radioisotopes.- 3.5 Improved Extraction Efficiency of Gallium-67 After Irradiation of Zinc-68 with Protons.- 3.6 Chemistry and Concept for An Automated 72Se/72As Generator.- 3.7 Radiochemistry of Monoclonal Antibody Labeling.- 3.8 The Study on the Formulation of A Tc(V)-99m-DMS Lyophilized Instant Kit for Tumor Scintigraphy.- 3.9 A National Biomedical Tracer Facility.- 3.10 Tantalum-178-Labeled Radiopharmaceutical Synthesis Via The Intermediate Tantalum Pentachloride — A Potential Myocardial Perfusion Agent.- 3.11 Status of Lead and Bismuth for Radioimmunoimaging and Therapy.- 4.1 Use of Organolithium and Organomagnesium Reagents In Radiopharmaceutical Synthesis.- 4.2 Application of OrganosiliconChemistry to the Synthesis of Gamma and Positron Emitting Radiotracers for Use In Nuclear Imaging Studies.- 4.3 The Synthesis of Halogenated Radiopharmaceuticals using Organomercurials.- 4.4 Synthesis of Radiopharmaceuticals Via Organoboranes.- 4.5 Radiosotope Incorporation via Aryl and Alkenyl Trialkyltin Intermediates.- 5.1 Robots In the Radiopharmaceutical Laboratory: Will They Replace the Chemist?.- 5.2 The Use of Transducers for Automated Radiopharmaceutical Synthesis Procedures.- 5.3 Facilitating the Design and Operation of Computer-Controlled Radiochemistry Synthesizers with an “Electronic Toolbox”.- 5.4 Knowledge-Based Automated Radiopharmaceutical Manufacturing for Positron Emission Tomography.- 5.5 Robotic Thin Layer Chromatography Instrument for Synthetic Chemistry.- 5.6 Automated Radiochemical Processing for Clinical PET.- 5.7 Captive Solvent Methods for Fast, Simple, Carbon-11 Radioalkylation.- 6.1 Identity, Strength, Purity, Quality and Safety: Common Goals for New Drugs.- 6.2 Quality Assurance Considerations Related to “In-House” Radiopharmaceutical Preparations Utilizing Positron Emitting Radionuclides.- 6.3 The Role of High Performance Liquid Chromatography In Radiochemical/Radiopharmaceutical Synthesis and Quality Assurance.- 6.4 Experience from a National Quality Assurance System on Radiopharmaceuticals.- 6.5 Radiopharmaceutical Production for PET: Quality Assurance Practice, Experience and Issues.- 6.6 Post-Column Reactor Determination of Aluminum Concentration in Cyclotron Produced Radiorubidium.- 6.7 Implications of the Food, Drug and Cosmetic Act on the Quality Assurance of Radiopharmaceuticals used in the United States.- 6.8 Quality Assurance in Radiochemical/Radiopharmaceutical Manufacturing.- 7.1 Regulatory Control ofRadiopharmaceutics.- 7.2 Regulatory Control of Radiopharmaceuticals.- 7.3 Development of European Regulations on Radiopharmaceuticals.- 7.4 Regulation of Cyclotron Radiopharmaceutical Production and Distribution: An Agreement State Perspective.- 7.5 New Drug Approval Process for Radiopharmaceuticals.- 7.6 Abbreviated New Drug Applications (ANDAS): Future Trends in Radiopharmaceuticals.

< to archive...